Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:DMTX

Dimension Therapeutics (DMTX) Stock Price, News & Analysis

Dimension Therapeutics logo

About Dimension Therapeutics Stock (NASDAQ:DMTX)

Advanced Chart

Key Stats

Today's Range
$5.95
$5.95
50-Day Range
N/A
52-Week Range
$1.05
$6.10
Volume
N/A
Average Volume
150,214 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive DMTX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dimension Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DMTX Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
Pitch dimensions
KAYS - Kaya Holdings, Inc.
Anime Dimensions Codes (January 2023)
See More Headlines

DMTX Stock Analysis - Frequently Asked Questions

Dimension Therapeutics, Inc. (NASDAQ:DMTX) announced its quarterly earnings results on Monday, November, 6th. The biotechnology company reported ($0.68) EPS for the quarter, missing the consensus estimate of ($0.48) by $0.20. The biotechnology company earned $4.48 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dimension Therapeutics investors own include Palatin Technologies (PTN), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Aquinox Pharmaceuticals (AQXP), Bellicum Pharmaceuticals (BLCM) and Can-Fite BioPharma (CANF).

Company Calendar

Last Earnings
11/06/2017
Today
8/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NASDAQ:DMTX
CIK
1592288
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NASDAQ:DMTX) was last updated on 8/10/2025 by MarketBeat.com Staff
From Our Partners